Sign Up to like & get recommendations! 0
Published in 2020 at "Experimental eye research"
DOI: 10.1016/j.exer.2020.108104
Abstract: Age-related macular degeneration (AMD) and proliferative diabetic retinopathy (DR) are two of the most common and severe causes of vision loss in the population. Both conditions are associated with excessive levels of vascular endothelial growth… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Thrombosis research"
DOI: 10.1016/j.thromres.2018.07.015
Abstract: BACKGROUND Hypoxia within acute venous thrombi is thought to drive resolution through stabilisation of hypoxia inducible factor 1 alpha (HIF1α). Prolyl hydroxylase domain (PHD) isoforms are critical regulators of HIF1α stability. Non-selective inhibition of PHD… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-60705-z
Abstract: Fine needle diathermy (FND) is an effective method to destroy and regress pathologic corneal blood and lymphatic vessels. However, it is unknown whether FND itself causes a rebound corneal neovascularisation and whether that can be… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Klinische Monatsblatter fur Augenheilkunde"
DOI: 10.1055/s-0042-123833
Abstract: Choroidal neovascularisation (CNV) in the context of exsudative age-related macular degeneration (nAMD) can be divided into type 1 (occult) and type 2 (classical) membranes. Retinal angiomatous proliferation (RAP) or polypoidal choroidal vasculopathy (PCV) are "rare… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-252270
Abstract: A boy in early adolescence presented with a 1-week history of visual acuity impairment in his right eye (RE). Fundus examination of the RE revealed an elevated yellow-greyish lesion in the inferior temporal juxtafoveolar area.… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Postgraduate Medical Journal"
DOI: 10.1136/postgradmedj-2019-136560
Abstract: A 61-year-old man presented with floaters in his right eye for the past 2 weeks. He had a history of poorly controlled type 2 diabetes mellitus for the past 16 years along with deranged renal… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Ophthalmologica"
DOI: 10.1159/000453550
Abstract: Background/Aim: Immune cells, e.g. microglial cells of the retina, appear to be involved in pathological processes in neovascular age-related macular degeneration. Therefore, the purpose of this study was to immunohistochemically check the expression of various… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Ophthalmic research"
DOI: 10.1159/000529342
Abstract: INTRODUCTION To report 2-year outcomes of intravitreal injection of high-dose conbercept (1 mg 2+PRN scheme) for subjects with myopic choroidal neovascularization (mCNV) and idiopathic choroidal neovascularization (iCNV) by optical coherence tomography angi-ography (OCTA) follow-up. METHODS… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Therapeutic Advances in Neurological Disorders"
DOI: 10.1177/17562864221141133
Abstract: Background: Intraplaque neovascularisation (IPN) is a component of vulnerable atherosclerotic plaque, which is a biomarker of cardiovascular events. However, the identification of patients with high probability of ischaemic events after carotid artery stenting (CAS) is… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0169865
Abstract: Purpose Inhibiting VEGF is the gold standard treatment for neovascular age-related macular degeneration (AMD). It is also effective in preventing retinal oedema and neovascularisation (NV) in diabetic retinopathy (DR) and retinal vein occlusions (RVO). Neuropilin… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10071557
Abstract: Age-related macular degeneration (AMD) is currently the main cause of severe visual loss among older adults in developed countries. The pathophysiology has not been clarified, but oxidative stress is believed to play a major role.… read more here.